Brief: Aap Implantate will not achieve previous FY 2016 sales and EBITDA forecast for continued operation

aap Implantate AG

15/12/2016 09:39

Dec 15 (Reuters) - Aap Implantate AG  AAQG.DE : 
    * aap updates forecast for financial year 2016 due to delays 
in sales development in various markets 
    * Announces that it will not achieve previous sales and 
EBITDA forecast for financial year 2016 for continued operation 
    * Adjusts its forecast for financial year 2016 for continued 
operation and now anticipates sales between 11.0 million euros 
and 12.1 million euros ($12.71 million)as well as an EBITDA of 
-7.5 million to -7.0 million euros 
    * For 2016 EBITDA of group (continued and discontinued 
operation including deconsolidation profit from sale of aap 
biomaterials gmbh) company anticipates a value of between 16.5 
million and 17.0 million euros 
    * Management board aims at a ce approval and closing of a 
license deal in financial year 2017 which will have visible 
influence on financial figures 
    * Reasons for this adjustment are delays in sales 
development in various markets leading to a sales shift in 
financial year 2017 
 
Source text for Eikon:  ID:nEQb0WNsV  
Further company coverage:  AAQG.DE  
 
($1 = 0.9523 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 722 0920;))